SENORES
Invest with MTF
Invest Now
Invest in Senores Pharmaceuticals with 3.05X leverage
Performance
- Low
- ₹800
- High
- ₹838
- 52 Week Low
- ₹440
- 52 Week High
- ₹877
- Open Price₹800
- Previous Close₹796
- Volume469,527
- 50 DMA₹803.37
- 100 DMA₹777.30
- 200 DMA₹711.39
Investment Returns
- Over 1 Month + 4.06%
- Over 3 Month + 4.31%
- Over 6 Month + 21.75%
- Over 1 Year + 55.88%
Smart Investing Starts Here Start SIP with Senores Pharmaceuticals for Steady Growth!
Senores Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 37.3
- PEG Ratio
- 0.6
- Market Cap Cr
- 3,786
- P/B Ratio
- 4.7
- Average True Range
- 29.39
- EPS
- 22.06
- Dividend Yield
- 0
- MACD Signal
- -0.24
- RSI
- 54.29
- MFI
- 75.11
Senores Pharmaceuticals Financials
Senores Pharmaceuticals Technicals
EMA & SMA
Current Price
₹822.10
+
25.65
(3.22%)
- Bearish Moving Average 0
- Bullish Moving Average 16
- 20 Day
- ₹808.22
- 50 Day
- ₹803.37
- 100 Day
- ₹777.30
- 200 Day
- ₹711.39
Resistance and Support
820.13
- R3 878.57
- R2 858.43
- R1 840.27
- S1 801.97
- S2 781.83
- S3 763.67
Senores Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2026-01-20 | Quarterly Results & Others | To consider other business matters. |
| 2026-01-07 | Others | Inter alia, 1. To consider and evaluate proposals for raising funds by way of issue of convertible warrants on preferential basis to the promotors/promoter group. |
| 2025-11-06 | Quarterly Results | |
| 2025-07-23 | Quarterly Results & Others | To consider other business matters. |
| 2025-05-15 | Audited Results |
Senores Pharmaceuticals F&O
About Senores Pharmaceuticals
- NSE Symbol
- SENORES
- BSE Symbol
- 544319
- Managing Director
- Mr. Swapnil Jatinbhai Shah
- ISIN
- INE0RB801010
Similar Stocks to Senores Pharmaceuticals
Senores Pharmaceuticals FAQs
Senores Pharmaceuticals share price is ₹822 As on 19 February, 2026 | 01:27
The Market Cap of Senores Pharmaceuticals is ₹3786.1 Cr As on 19 February, 2026 | 01:27
The P/E ratio of Senores Pharmaceuticals is 37.3 As on 19 February, 2026 | 01:27
The PB ratio of Senores Pharmaceuticals is 4.7 As on 19 February, 2026 | 01:27
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.